Mast cells in diffuse large B-cell lymphoma; their role in fibrosis

Histopathology

Volumn 49, Issue 5, 2006, Pages 498-505

  Fukushima, H ^a   Ohsawa, M ^a   Ikura, Y ^a   Naruko, T ^b   Sugama, Y ^a   Suekane, T ^a   Kitabayashi, C ^a   Inoue, T ^b   Hino, M ^a   Ueda, M ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Chymase; Diffuse large B cell lymphoma; Fibrosis; Interleukin 4; Mast cell; Tryptase

Indexed keywords

CHYMASE; INTERLEUKIN 4; TRYPTASE;

ARTICLE; B CELL LYMPHOMA; CELL DENSITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAST CELL; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHYMASES; FEMALE; FIBROSIS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-4; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MAST CELLS; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; TRYPTASES; TUMOR MARKERS, BIOLOGICAL;

EID: 33750334538     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02534.x     Document Type: Article

References (37)

1. Nilsson G, Costa JJ, Metcalfe DD. Mast cells and Basophils. In Gallin JI, Snyderman R eds. Inflammation: basic principles and clinical correlates, 3rd edn. Philadelphia: Lippincott Williams & Wilkins 1999; 97-117.
2. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 1995; 155; 297-307.
3. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neural protease compositions. Proc. Natl Acad. Sci. USA 1986; 83; 4464-4468.
4. Marone G, Casolaro V, Patella V, Florio G, Triggiani M. Molecular and cellular biology of mast cells and basophils. Int. Arch. Allergy Immunol. 1997; 114; 207-217.
5. Weidner N, Austen KF. Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. J. Invest. Dermatol. 1991; 96; 26S-31S.
6. Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J, Nakahara T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 1998; 91; 187-195.
7. Yanagida M, Fukamachi H, Ohgami K et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 1995; 86; 3705-3714.
8. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432; 332-337.
9. Iamaroon A, Pongsiriwet S, Jittidecharaks S, Pattanaporn K, Prapayasatok S, Wanachantararak S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J. Oral. Pathol. Med. 2003; 32; 195-199.
10. Kondo S, Kagami S, Kido H, Strutz F, Müller GA, Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 2001; 12; 1668-1676.
11. Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000; 88; 2686-2692.
12. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 1990; 265; 22348-22357.
13. Fang KC, Raymond WW, Blout JL, Caughey GH. Dog mast cell α-chymase activates progelatinase B by cleaving the Phe88-Gin89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 1997; 272; 25628-25635.
14. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr 84 bond by mast cell chymase. J. Biol. Chem. 1994; 269; 18134-18140.
15. Leskinen MJ, Lindstedt KA, Wang Y, Kovanen PT. Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degeneration and disruption of focal adhesions. Arterioscler. Tromb. Vasc. Biol. 2003; 23; 238-243.
16. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J. Biol. Chem. 1997; 272; 7127-7131.
17. Lindstedt KA, Wang Y, Shiota N et al. Activation of paracrine TGF-β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J. 2001; 15; 1377-1388.
18. Tomimori Y, Muto T, Saito K et al. Involvement of mast cell chymase in bleomycin-induced pulmonary fiborosis in mice. Eur. J. Pharmacol. 2003; 478; 179-185.
19. Ikenaga KK, Hara M, Higuchi K et al. Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis. Circ. J. 2003; 67; 881-884.
20. Jones SE, Gilbert RE, Kelly DJ. Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes. J. Diabetes Complications 2004; 18; 309-315.
21. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 2003; 107; 2555-2558.
22. Ohishi M, Ueda M, Rakugi H et al. Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions. J. Hypertens. 1999; 17; 547-553.
23. Mitani Y, Ueda M, Maruyama K et al. Mast cell chymase in pulmonary hypertension. Thorax 1999; 54; 88-90.
24. Yamada M, Ueda M, Naruko T et al. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int. 2001; 59; 1374-1381.
25. Matsuo T, Ikura Y, Ohsawa M et al. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology 2003; 43; 538-549.
26. Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J. Hepatol. 2003; 33; 961-966.
27. Sharma VK, Agrawal AK, Pratarp VK, Nagar AM, Mehrotra ML. Mast cell reactivity in lymphoma: a preliminary communication. India. J. Cancer 1992; 29; 61-65.
28. Molin D, Edström A, Glimelius I et al. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br. J. Haematol. 2002; 119; 122-124.
29. Rabatti D, Vacca A, Marzollo A et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int. J. Cancer 2000; 85; 171-175.
30. Fukushima N, Satoh T, Sano M, Tokunaga O. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma. Leuk. Lymphoma 2001; 42; 709-720.
31. Buckley MG, McEuen AR, Wallis AF. The detection of mast cell subpopulations in formalin-fixed human tissues using a new monoclonal antibody specific for chymase. J. Pathol. 1999; 189; 138-143.
32. Dimitriadou V, Koutsilieris M. Mast cell-tumor cell interactions: for or against tumor growth and metastasis? Anticancer Res. 1997; 17; 1541-1550.
33. Nagata M, Shijubo N, Walls AF, Ichimiya S, Abe S, Sato N. Chymase-positive mast cells in small sized adenocarcinoma of the lung. Virchows Arch. 2003; 443; 565-573.
34. Naik R, Pai MR. Mast cell numbers in lymphnode lesions. Indian. J. Pathol. Microbiol. 1998; 41; 153-156.
35. Bullens DMA, Rafiq K, Kasran A, Van Gool SW, Ceuppens JL. Naïve human T cells can be a source of IL-4 during primary immune responses. Clin. Exp. Immunol. 1999; 118; 384-391.
36. Brandit E, Woerly G, Younes AB, Loiseau S, Capron M. IL-4 production by human polymorphonuclear neutrophils. J. Leuk. Biol. 2000; 68; 125-130.
37. Riekki R, Harvima IT, Jukkola A, Risteli J, Oikarinen A. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy. Exp. Dermatol. 2004; 13; 364-371.